Will Shares of HEXO Sink or Swim in 2020?

Now that 2019 is behind us we’re beginning to see a breakout among the pack of publicly traded cannabis companies, and Hexo (HEXO) stock seems like it could go any direction. One of the main concerns some investors have is that HEXO is not as insulated from the woes of the Canadian recreational market as […]

Is GW Pharmaceuticals (GWPH) a Buy Before it Reports Earnings?

Earlier this week, an H.C. Wainwright analyst initiated coverage of GW Pharmaceuticals (GWPH), adding to the buzz already surrounding this increasingly popular cannabis stock. On Wednesday, H.C. Wainwright analyst Douglas Tsao initiated coverage, giving the stock a “Buy” rating and $170 price target. In a note to investors, Tsao said that he expects GWPH stock […]